Qadeer Imrana
Senior Fellow, Centre for Women's Development Studies, 25 Bhai Vir Singh Marg, New Delhi 110 001, India.
Indian J Med Ethics. 2010 Oct-Dec;7(4):209-15. doi: 10.20529/IJME.2010.079.
New legislation can be oppressive for a significant population depending upon the politics of its drafters. The current upsurge of the surrogacy trade in India, and the label of a "win-win" situation that it has acquired, points towards an unfettered commercialisation of assisted reproductive technology and the practice of surrogacy that is blinding its middle class users as well as providers, policy makers and law makers, and charging an imagination that is already caught up in spiralling consumerism. This paper analyses the Draft Assisted Reproductive Technology (Regulation) Bill and Rules, 2008, in the Indian socioeconomic context. It identifies the interests of the affected women, and examines the contradictions of the proposed Bill with their interests, as well as with current health and population policies, confining itself to the handling of surrogacy and not the entire content of the Bill. The bases of the analytical perspective used are: the context of poverty and the health needs of the Indian population; the need to locate surrogacy services within the overall public health service context and its epidemiological basis; the need to restrain direct human experimentation for the advancement of any technology; the use of safer methods; and, finally, the rights of surrogate mothers and their babies, in India, as opposed to the compulsion or dynamics of the medical market and reproductive tourism.
新立法可能会对相当一部分人造成压迫,这取决于起草者的政治立场。印度目前代孕交易的激增,以及它所获得的“双赢”局面的标签,表明辅助生殖技术和代孕行为正不受约束地商业化,这蒙蔽了中产阶级使用者、提供者、政策制定者和立法者的双眼,也冲击了已经陷入螺旋式消费主义的想象力。本文在印度社会经济背景下分析了《2008年辅助生殖技术(监管)法案》及相关规则草案。它确定了受影响女性的利益,并审视了拟议法案与其利益以及当前健康和人口政策之间的矛盾,本文仅限于代孕问题的处理,而非该法案的全部内容。所采用分析视角的依据包括:印度人口的贫困背景和健康需求;将代孕服务置于总体公共卫生服务背景及其流行病学基础中的必要性;为推动任何技术而限制直接人体实验的必要性;使用更安全方法的必要性;最后,在印度,代孕母亲及其婴儿的权利,这与医疗市场和生殖旅游的强制要求或动态情况形成对比。